NCT04023084View on ClinicalTrials.gov

Response of Children With Atopic Dermatitis (Eczema) to Eucrisa

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 3, 2019

Primary Completion Date

February 11, 2022

Study Completion Date

February 11, 2022

Conditions
Atopic DermatitisEczema
Interventions
DRUG

Crisaborole

Crisaborole 2% topical ointment applied twice daily to affected area(s) for 28 days

Trial Locations (1)

60611

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Ann & Robert H Lurie Children's Hospital of Chicago

OTHER